NCT02133196 2026-03-24T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung CancerNational Institutes of Health Clinical Center (CC)Phase 2 Recruiting85 enrolled
NCT05493566 2026-02-12Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung CancerEmory UniversityPhase EARLY_PHASE1 Recruiting15 enrolled